Skip to main navigation
Orchestra BioMed logo

Close

Investor Relations
  • Who We Are
    • Our Approach
    • Our People
    • Careers
  • Our Innovations
    • Pipeline
    • Therapeutic Areas
    • Virtue® SAB
    • BackBeat CNT™
    • FreeHold Retractors
  • Investor Relations
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
  • Financial & Filings
    • SEC Filings
    • Annual Reports and Proxy Satements
  • IR Resources
    • Email Alerts
    • Contact IR
  • Contact Us
Menu - sns
Twitter Linkedin

Investor Relations

SEC Filings

Filing date Form Description Filing Group View
Mar 24, 2023 8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
0001213900-23-022800.pdf
0001213900-23-022800.rtf
0001213900-23-022800.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 13, 2023 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001213900-23-019415.pdf
0001213900-23-019415.rtf
0001213900-23-019415.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 14, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0000080255-23-002724.pdf
0000080255-23-002724.rtf
Feb 14, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0001104659-23-021810.pdf
0001104659-23-021810.rtf
0001104659-23-021810.xls
Feb 07, 2023 SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
0001193125-23-025835.pdf
0001193125-23-025835.rtf
0001193125-23-025835.xls
Feb 06, 2023 SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
0001437749-23-002597.pdf
0001437749-23-002597.rtf
Feb 01, 2023 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
0001062993-23-001818.pdf
0001062993-23-001818.rtf
0001062993-23-001818.xls
Feb 01, 2023 4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
0001062993-23-001819.pdf
0001062993-23-001819.rtf
0001062993-23-001819.xls
Jan 31, 2023 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001213900-23-006448.pdf
0001213900-23-006448.rtf
0001213900-23-006448.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 30, 2023 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
0000899243-23-002948.pdf
0000899243-23-002948.rtf
0000899243-23-002948.xls

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 124 results

Data provided by Kaleidoscope.

Orchestra BioMed logo
  • Footerlink - who we are

    Who We Are Our Approach Our People Careers
  • Footerlink - our innovations

    Our Innovations Pipeline Therapeutic Areas Virtue® SAB BackBeat CNT™ FreeHold Retractors
  • Footerlink - news & events

    Investor Relations Overview News & Events Stock Information Corporate Governance Financial & Filings IR Resources
  • Footerlink - contact us

    Contact Us
Menu - sns
Twitter Linkedin

© 2023 Orchestra BioMed Inc. Virtue®, BackBeat CNT™ FreeHold Duo®, FreeHold Trio® and Orchestra BioMed™ are trademarks of Orchestra BioMed.
All other trademarks are trademarks of their respective owners.
SM-0020 Rev 01

Btn - disclaimer

Disclaimer